Advanced Prostate Cancer

/Advanced Prostate Cancer

Latest Treatments & Shared Decision Making

https://vimeo.com/220740406#t=22s

By | June 12th, 2017|Advanced Prostate Cancer|0 Comments

Is Jevtana used by anyone? Anyone at all? What is your quality of life “if” you are using Jevtana?

We're wondering if anyone is using Jevtana as a treatment for advanced stage prostate cancer.  We're wondering what Jevtana's quality of  life impact is on patients. Please email me at info@malecare.org if you are using it .... do tell us what your Jevtana experience is like.

By | June 9th, 2017|Advanced Prostate Cancer|1 Comment

Malecare, Yale, Memorial Sloan Kettering and M.D. Anderson talk about Latest Treatments & Shared Decision Making

Breakthroughs in Prostate Cancer https://vimeo.com/220740406 An interesting discussion about prostate cancer breakthroughs, some of which patients can use today, with: Philip Kantoff, MD, Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center Daniel Petrylak, MD, Director, Genitourinary Oncology, Co-Director, Signal Transduction Research Program, Yale University Cancer Center Sumit Subudhi, MD, Assistant Professor, Department of Genitourinary [...]

By | June 9th, 2017|Advanced Prostate Cancer|1 Comment

Statins and Xtandi vs Statins and Zytiga

A new study from Italy showed that using statins while on Xtandi would help extend life longer than without using the statins. The study compared the use of statins in men taking Xtandi and men taking Zytiga. While statins helped men who were taking Xtandi, taking statins was of no help to men taking Zytiga. [...]

By | June 1st, 2017|Advanced Prostate Cancer|0 Comments

Breast Cancer Test Can Tell If Hormone Therapy Will Work On Prostate Cancer

A breast cancer test may be adapted to help men with advanced stage prostate cancer know – in advance - if androgen deprivation therapy (ADT) will help them. Researchers from UCSF and the University of Michigan investigated genetic subtypes of prostate cancer, to see what the difference could predict. The researchers divided prostate tumors into [...]

By | May 30th, 2017|Advanced Prostate Cancer|0 Comments

Jevtana, Taxotere, Zytiga and Xtandi discussion – video from ASCO 2016

As we get ready for next weeks' American Society of Clinical Oncology annual meeting, I thought advanced prostate cancer patients would find it helpful to see this thirty minute review from last years meeting. Click >>>  https://www.patientpower.info/video/asco-advanced-prostate-cancer-roundtable-discussion     http://malecare.org/the-development-of-a-novel-blood-biomarker-for-detecting-ar-v7-and-resistance-to-zytiga-and-xtandi/

By | May 23rd, 2017|Advanced Disease, Advanced Prostate Cancer|0 Comments

Xtandi May Work Better With TET

Androgen deprivation therapy (ADT) is a first line treatment for men when prostate cancer has spread beyond the prostate. Men die from prostate cancer after their disease becomes castration resistant prostate cancer (CRPC). Anti-androgen treatments such as Enzalutamide (Xtandi) have lengthened the life of thousands of advanced prostate cancer men around the world. Ultimately, even [...]

Quality of Life Improvements Help Extend Life While On Xofigo

You may live longer if you feel good about life while taking radium-223 (Xofigo). Dr Neal Shore from the Carolina Urologic Research Center studied how health related quality of life (HRQoL) might be related to overall survival while being treated for advanced prostate cancer with Xofigo. Approximately 800 men with advanced prostate cancer were asked [...]

Testosterone Levels May Predict Hormone Treatment Effectiveness

Advanced prostate cancer patients who started androgen deprivation treatment (ADT) treatment with low testosterone levels had worse 1-year progression-free and overall survival after continuous ADT than men with higher testosterone levels. This means that men who are about to start hormone therapy should have their testosterone tested. Those with low testosterone levels should ask their [...]

Urologists Fail to Complete Psycho-Social and Sexual Histories of Prostate Cancer Patients

 Malecare and the University of Minnesota collaborated on the first study to investigate what gay and bisexual men are offered and what they try as rehabilitation to address the sexual and urinary effects of prostate cancer treatment.   Gay and bisexual men with prostate cancer (N=193) from Malecare's online and in-person support groups completed survey questions asking [...]

By | April 26th, 2017|Advanced Prostate Cancer, Gay, Newly Diagnosed|2 Comments